We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Robotic Platform Enables More Accurate Diagnosis of Cancer Cells

By LabMedica International staff writers
Posted on 25 Oct 2023

For more than a century, the field of histology, which falls under pathology and focuses on changes in tissue, has relied on an old-school method. More...

This involves slicing tissue samples into extremely thin sections—each about seven times thinner than a human hair—and then examining them for any abnormal changes under a microscope. The downside of this traditional technique is that it leads to misdiagnosis in about one out of every six people, often missing cancer cells. Now, scientists have integrated biomedical technology with mechanical engineering to create a robotic system that not only diagnoses cancer more precisely but also offers three-dimensional insights into the spatial arrangement of cells.

Researchers from ETH Zurich (Zurich, Switzerland) and the University of Zurich (Zurich, Switzerland) are working on this robotic platform designed to improve the accuracy of cancer diagnosis by rapidly quantifying tissue samples in their entirety. The procedure involves four stages. First, the tissue sample is automatically made transparent. Second, any unusual cells are quickly stained or colored. The third phase consists of generating a 3D image that maps out the cancer cells; the technology for this is already available. The last phase involves analyzing the tissue using 3D imaging software and training algorithms. This novel approach eliminates the need for labor-intensive preparation and slicing of tissue samples; instead, the entire tissue sample—like a lymph node—is preserved and fully examined. The 3D digital images showing the marked cells can be accessed online whenever needed.

Currently, the robot prototype is functional in the lab and can maneuver samples as required. However, it's not yet completely market-ready. While the team can provide preliminary services like automatically rendering sent-in tissue samples transparent and generating labeled 3D images swiftly, the software still needs fine-tuning. The researchers aim to commercialize this robotic system, offering research laboratories and healthcare facilities a dependable and effective tool that could revolutionize the way cancer diagnosis is conducted in the digital age.

Related Links:
ETH Zurich 
University of Zurich 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.